Page last updated: 2024-08-16

3,3',4,5'-tetrahydroxystilbene and Bowel Diseases, Inflammatory

3,3',4,5'-tetrahydroxystilbene has been researched along with Bowel Diseases, Inflammatory in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Chueh, TL; Ho, CT; Lin, WS; Nagabhushanam, K; Pan, MH1
Khare, S; Khare, T; Palakurthi, S; Palakurthi, SS; Shah, BM1
Gong, W; Gu, G; Hong, Z; Liu, J; Liu, P; Ren, H; Ren, J; Wang, G; Wu, X; Yu, J; Zhao, F; Zhao, Y; Zheng, T1
Baldelli, F; Biagioli, M; Carino, A; Cipriani, S; Costantino, G; Distrutti, E; Donini, A; Fiorucci, C; Fiorucci, S; Graziosi, L; Marchianò, S; Mencarelli, A1
Kundu, JK; Lee, JS; Na, HK; Surh, YJ; Youn, J1

Reviews

1 review(s) available for 3,3',4,5'-tetrahydroxystilbene and Bowel Diseases, Inflammatory

ArticleYear
Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.
    International journal of molecular sciences, 2020, May-31, Volume: 21, Issue:11

    Topics: Animals; Benzoquinones; Biological Products; Biomimetics; Caffeic Acids; Curcumin; Cytokines; Exosomes; Humans; Inflammation; Inflammatory Bowel Diseases; Insecta; Macromolecular Substances; Nanomedicine; Oxidative Stress; Phenylethyl Alcohol; Phytochemicals; Plant Extracts; Polysaccharides; Quercetin; Resveratrol; Stilbenes; Transcription Factors; Translational Research, Biomedical; Vasoactive Intestinal Peptide; Zingiber officinale

2020

Other Studies

4 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Bowel Diseases, Inflammatory

ArticleYear
Piceatannol and 3'-Hydroxypterostilbene Alleviate Inflammatory Bowel Disease by Maintaining Intestinal Epithelial Integrity and Regulating Gut Microbiota in Mice.
    Journal of agricultural and food chemistry, 2023, Feb-01, Volume: 71, Issue:4

    Topics: Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL

2023
CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease.
    Clinical and translational medicine, 2021, Volume: 11, Issue:2

    Topics: Animals; Caco-2 Cells; Chemokine CCL4; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Ligands; Male; Mice; Mice, Inbred C57BL; Nanoparticle Drug Delivery System; Stilbenes; Syk Kinase; THP-1 Cells

2021
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases.
    Inflammatory bowel diseases, 2017, 12-19, Volume: 24, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Adult; Animals; Antipruritics; Colitis; Cytokines; Disease Models, Animal; Female; Humans; Inflammation; Inflammatory Bowel Diseases; Intestinal Diseases; Ketotifen; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Stilbenes; Syk Kinase

2017
Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis.
    Nutrition and cancer, 2009, Volume: 61, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colonic Neoplasms; Dextran Sulfate; DNA-Binding Proteins; Down-Regulation; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; I-kappa B Kinase; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Resveratrol; STAT3 Transcription Factor; Stilbenes; Time Factors

2009